Molina Healthcare Inc (MOH) Price Target Raised to $74.00

Molina Healthcare Inc (NYSE:MOH) had its price target increased by equities research analysts at Jefferies Group LLC from $64.00 to $74.00 in a note issued to investors on Friday, November 3rd. The firm presently has a “hold” rating on the stock. Jefferies Group LLC’s target price indicates a potential downside of 5.02% from the stock’s current price. Jefferies Group also issued estimates for Molina Healthcare’s Q1 2018 earnings at $0.65 EPS, Q2 2018 earnings at $0.72 EPS, Q3 2018 earnings at $0.82 EPS and FY2018 earnings at $3.06 EPS.

Several other brokerages have also issued reports on MOH. Zacks Investment Research lowered Molina Healthcare from a “hold” rating to a “sell” rating in a report on Tuesday, October 3rd. Deutsche Bank AG reiterated a “hold” rating and set a $72.00 price target on shares of Molina Healthcare in a report on Wednesday, August 9th. Bank of America Corporation boosted their price objective on Molina Healthcare from $59.00 to $60.00 and gave the company an “underperform” rating in a research report on Friday, July 14th. Wolfe Research raised Molina Healthcare from a “market perform” rating to an “outperform” rating in a research note on Monday, October 23rd. Finally, Morgan Stanley raised Molina Healthcare from an “underweight” rating to an “overweight” rating and boosted their price objective for the stock from $65.00 to $68.00 in a research note on Thursday, August 17th. Three investment analysts have rated the stock with a sell rating, nine have given a hold rating and six have assigned a buy rating to the company’s stock. The stock has an average rating of “Hold” and an average target price of $64.30.

Shares of Molina Healthcare (NYSE MOH) traded up $1.01 during midday trading on Friday, hitting $77.91. 874,400 shares of the company were exchanged, compared to its average volume of 1,272,789. The company has a market capitalization of $4,390.53, a PE ratio of 23.88 and a beta of 0.91. Molina Healthcare has a fifty-two week low of $42.56 and a fifty-two week high of $80.65. The company has a current ratio of 1.29, a quick ratio of 1.29 and a debt-to-equity ratio of 1.06.

Molina Healthcare (NYSE:MOH) last issued its quarterly earnings results on Thursday, November 2nd. The company reported ($1.62) earnings per share for the quarter, missing the Zacks’ consensus estimate of $0.23 by ($1.85). The company had revenue of $5.03 billion during the quarter, compared to analysts’ expectations of $4.95 billion. Molina Healthcare had a positive return on equity of 17.76% and a negative net margin of 1.76%. The company’s revenue for the quarter was up 10.7% compared to the same quarter last year. During the same period in the prior year, the business posted $0.85 EPS. analysts expect that Molina Healthcare will post -3.88 EPS for the current year.

COPYRIGHT VIOLATION WARNING: This news story was originally reported by TrueBlueTribune and is the sole property of of TrueBlueTribune. If you are accessing this news story on another publication, it was illegally copied and reposted in violation of US and international trademark and copyright law. The legal version of this news story can be accessed at https://www.truebluetribune.com/2017/11/14/molina-healthcare-inc-moh-pt-raised-to-74-00-at-jefferies-group-llc.html.

In other news, insider Lisa A. Rubino sold 5,378 shares of Molina Healthcare stock in a transaction on Monday, August 21st. The stock was sold at an average price of $60.30, for a total value of $324,293.40. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Daniel Cooperman sold 4,500 shares of Molina Healthcare stock in a transaction on Tuesday, November 7th. The shares were sold at an average price of $78.79, for a total value of $354,555.00. Following the completion of the transaction, the director now owns 9,087 shares in the company, valued at approximately $715,964.73. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 373,458 shares of company stock worth $24,394,739. Corporate insiders own 6.20% of the company’s stock.

A number of institutional investors and hedge funds have recently made changes to their positions in MOH. Tavio Capital LLC lifted its holdings in Molina Healthcare by 418.0% during the 3rd quarter. Tavio Capital LLC now owns 537,192 shares of the company’s stock worth $36,937,000 after buying an additional 433,485 shares during the period. Acadian Asset Management LLC lifted its holdings in Molina Healthcare by 6,812.6% during the 2nd quarter. Acadian Asset Management LLC now owns 415,587 shares of the company’s stock worth $28,748,000 after buying an additional 409,575 shares during the period. Koch Industries Inc. acquired a new position in Molina Healthcare during the 2nd quarter worth about $323,000. York Capital Management Global Advisors LLC acquired a new position in Molina Healthcare during the 2nd quarter worth about $19,289,000. Finally, Naya Capital Management UK Ltd. lifted its holdings in Molina Healthcare by 225.7% during the 2nd quarter. Naya Capital Management UK Ltd. now owns 363,093 shares of the company’s stock worth $25,119,000 after buying an additional 251,600 shares during the period. 95.04% of the stock is currently owned by hedge funds and other institutional investors.

About Molina Healthcare

Molina Healthcare, Inc offers Medicaid-related solutions for low-income families and individuals, and assists government agencies in their administration of the Medicaid program. The Company operates through three segments: Health Plans, Molina Medicaid Solutions and Other, which includes its Pathways Health and Community Support LLC (Pathways) business.

Analyst Recommendations for Molina Healthcare (NYSE:MOH)

Receive News & Ratings for Molina Healthcare Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare Inc and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply